Results 7,461-7,480 of 20,758 for speaker:Alan Kelly
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: That is very welcome news. I would encourage the utilisation of the public system to the greatest extent possible.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: I thank the witnesses for the clarity they have brought. It has been pretty good.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: I thank the committee very much for accommodating me. I am attending another committee at the same time, so I have been in and out. I have a few quick questions. With regard to disclosure, we know the Civil Liability (Amendment) Act 2017 is in place and that the patient safety Bill will come into place. Disclosure, including mandatory disclosure, is one of the biggest issues that arose...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: What changes does that mean from a day-to-day point of view?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: What is the difference for the SCA post Scally, compared with the pre-Scally report position?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: In layman's terms, there cannot actually be any change.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: Has the HSE set up an office to deal with all of the implementation of open disclosure?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: The HSE will have to tick-tack with the SCA quite a bit.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: How many times have the HSE and SCA met on this issue since the Scally report was published?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: I am specifically asking about the HSE and SCA. How many times have they met following Scally's recommendations?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: Would it be unusual if they had not discussed it?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: Who is that lady?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: What is her title? What does she do?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: That is helpful. I have a follow-up question for clarity. We spoke about colposcopy clinics which receive notifications of abnormalities. There is an obvious increase in demand. We had a lot of discussion here previously about colposcopists and we are still looking for some minutes, which we have never found, for the famous second meeting. Are there issues that we need to know about? We...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: It does not matter.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: I think that needs to be dialled up. I am just getting information. We all know that we are discussing this, by and large, because of the amazing Vicky Phelan and her refusal to sign a non-disclosure agreement. Since her case, have there been issues with confidentiality or people being asked to sign non-disclosure agreements? Is that just gone?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: I just wanted to make sure it has not happened since Mr. Breen was last here.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: I have a final few questions. I am trying to be exhaustive. This question is for the HSE though I am not sure who wants to answer. After the Scally report, and before it in fairness, since I do not want to misrepresent him, the acting chief executive officer, John Connaghan, said that he would not be shy about looking into what Dr. Scally reported regarding internal decision-making and...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: That is the most important part. The 50 recommendations are by far the most important element of the report.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: I am not sure that answers my question.